Emerson Wins Lonza Automation Contract for Biopharmaceutical Plant in Singapore
Emerson Process Management (Austin, TX) has been selected by Lonza Group, Ltd. (Basel, Switzerland) to provide engineering and design services, and digital automation architecture and control technologies for a new Lonza biopharmaceutical plant in Singapore.
Emerson Process Management (Austin, TX) has been selected by Lonza Group, Ltd. (Basel, Switzerland) to provide engineering and design services, and digital automation architecture and control technologies for a new Lonza biopharmaceutical plant in Singapore.
Having installed the automation architecture in Lonza’s first biopharmaceutical plant in Singapore, Emerson was chosen to implement its PlantWeb technologies in the new plant that is expected to be completed in 2010 at a cost of $350 million.
Lonza will use an array of Emerson products and services, including PlantWeb digital automation architecture; DeltaV digital automation system; and intelligent digital devices, including Fisher and Baumann control valves with Fieldvue digital valve controllers, Rosemount flowmeters and analyzers, Micro Motion Coriolis flowmeters, and Fisher pressure regulators.
The Solution Lies with SOLBIOTE™: Achieving Sustainability, a Growing Focus in Biopharma
October 28th 2024The nexus between biopharmaceuticals and sustainability is seemingly far apart, however, it is increasingly recognized as an inevitable challenge. It is encouraged to take a sustainable approach to reducing the environmental impact of the production and supply of medicines while improving people's health; delivering the well-being of people and the planet. Yosuke Shimojo (Technical Value Support Section Manager, Nagase Viita) will unveil how SOLBIOTE™, a portfolio of injectable-grade saccharide excipients, would be a key for the biopharmaceutical development and achieving sustainability for a better future of the industry.
